US Patent 7897733 Rapamycin conjugates and antibodies
Patent 7897733 was granted and assigned to Pfizer Limited on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+390 characters)
Article
Patent abstract
Provided are rapamycin conjugates which are useful as immunogenic molecules for the generation of antibodies specific for rapamycin, for measuring levels of rapamycin or derivatives thereof; for isolating rapamycin binding proteins; and detecting antibodies specific for rapamycin or derivatives thereof. This invention also provides a rapamycin specific monoclonal antibody.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Craig E. Caufield0
Katherine L. Molnar-Kimber0
Timothy D. Ocain0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07897733 Rapamycin conjugates and antibodies US Patent 7897733 Rapamycin conjugates and antibodies
Infobox
Patent Number
078977330
Patent Number
78977330
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
078977330
Date of Patent
March 1, 2011
0Patent Application Number
112720700
Date Filed
November 14, 2005
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07897733 Rapamycin conjugates and antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07897733
Date of patent
March 1, 2011
Patent application number
11272070
Date Filed
November 14, 2005
Patent primary examiner
Find more entities like US Patent 7897733 Rapamycin conjugates and antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
